Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-12-001641
Filing Date
2012-04-03
Accepted
2012-04-02 17:45:24
Documents
16
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT slfcx_10k.htm 10-K 1565868
2 CERTIFICATION slfcx_ex311.htm EX-31.1 16143
3 CERTIFICATION slfcx_ex312.htm EX-31.2 15875
4 CERTIFICATION slfcx_ex313.htm EX-31.3 15816
5 CERTIFICATION slfcx_ex321.htm EX-32.1 6471
6 CERTIFICATION slfcx_ex322.htm EX-32.2 6518
7 CERTIFICATION slfcx_ex323.htm EX-32.3 6519
8 header.jpg GRAPHIC 3925
9 footer.jpg GRAPHIC 1951
10 stellar_auditsig.jpg GRAPHIC 15917
  Complete submission text file 0001354488-12-001641.txt   4078949

Data Files

Seq Description Document Type Size
11 slxcf-20111231.xml EX-101.INS 464268
12 slxcf-20111231.xsd EX-101.SCH 16876
13 slxcf-20111231_lab.xml EX-101.LAB 110713
14 slxcf-20111231_pre.xml EX-101.PRE 87269
15 slxcf-20111231_def.xml EX-101.DEF 21836
16 slxcf-20111231_cal.xml EX-101.CAL 41758
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31198 | Film No.: 12734768
SIC: 2834 Pharmaceutical Preparations